Antiplasmodial activity, structure–activity relationship and studies on the action of novel benzimidazole derivatives

Author:

Escala Nerea,Pineda Laura M.,Ng Michelle G.,Coronado Lorena M.,Spadafora Carmenza,del Olmo Esther

Abstract

AbstractMalaria cases and deaths keep being excessively high every year. Some inroads gained in the last two decades have been eroded especially due to the surge of resistance to most antimalarials. The search for new molecules that can replace the ones currently in use cannot stop. In this report, the synthesis of benzimidazole derivatives guided by structure–activity parameters is presented. Thirty-six molecules obtained are analyzed according to their activity against P. falciparum HB3 strain based on the type of substituent on rings A and B, their electron donor/withdrawing, as well as their dimension/spatial properties. There is a preference for electron donating groups on ring A, such as Me in position 5, or better, 5, 6-diMe. Ring B must be of the pyridine type such as picolinamide, other modifications are generally not favorable. Two molecules, 1 and 33 displayed antiplasmodial activity in the high nanomolar range against the chloroquine sensitive strain, with selectivity indexes above 10. Activity results of 1, 12 and 16 on a chloroquine resistance strain indicated an activity close to chloroquine for compound 1. Analysis of some of their effect on the parasites seem to suggest that 1 and 33 affect only the parasite and use a route other than interference with hemozoin biocrystallization, the route used by chloroquine and most antimalarials.

Funder

Ministery of Environment: Endowment for Water, Protected Areas and Wildlife, Panama

Sistema Nacional de Investigación, Secretaría Nacional de Ciencia, Tecnología e Innovación

Ministerio de Ciencia e Innovación

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference47 articles.

1. Ashley, E. A., Pyae Phyo, A. & Woodrow, C. J. Malaria. Lancet 391(10130), 1608–1621. https://doi.org/10.1016/s0140-6736(18)30324-6 (2018).

2. World Malaria Report. World Health Organization. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2021 (2021). Accessed 10 December 2022.

3. WHO recommends groundbreaking malaria vaccine for children at risk. https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk (2021). Accessed 10 December 2022.

4. Olotu, A. et al. Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children. N. Engl. J. Med. 374, 2519–2529. https://doi.org/10.1056/NEJMoa1515257 (2016).

5. Guideline for Malaria. World Health Organization. https://www.who.int/publications/i/item/guidelines-for-malaria (2021). Accessed 10 December 2022.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3